India Globalization Capital, Inc.(NYSE Amex Equities : IGC)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.26% | 203.42 | 1.3% | $752.26m | |
| GILD | Gilead Sciences, Inc. | 0.14% | 64.22 | 0.9% | $374.75m | |
| CELG | Celgene Corporation | 0.03% | 95.71 | 1.3% | $325.97m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 7.53% | 123.49 | 2.0% | $306.94m | |
| ILMN | Illumina, Inc. | -0.66% | 288.58 | 3.5% | $277.12m | |
| BIIB | Biogen Inc. | -0.48% | 232.06 | 1.3% | $268.05m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.16% | 184.24 | 1.9% | $256.63m | |
| EXAS | Exact Sciences Corporation | -1.14% | 117.87 | 24.1% | $239.89m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.93% | 295.02 | 2.6% | $203.40m | |
| A | Agilent Technologies, Inc. | -0.69% | 71.70 | 1.6% | $193.78m | |
| SRPT | Sarepta Therapeutics, Inc. | -6.34% | 95.07 | 14.7% | $184.59m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.05% | 77.40 | 4.3% | $97.47m | |
| INCY | Incyte Corporation | -0.59% | 85.56 | 2.5% | $96.06m | |
| GHDX | Genomic Health, Inc. | -1.12% | 73.52 | 1.8% | $85.99m | |
| SGEN | Seattle Genetics, Inc. | -2.01% | 78.36 | 6.5% | $79.57m |
Company Profile
India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications such as Alzheimer's disease, Parkinson's disease, and pain. It operates through the Infrastructure Business and Plant & Cannabinoids Business segments. The Infrastructure Business segment involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The Plant & Cannabinoids Business segment comprises the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.